Objective: The purpose of this study was to analyze the relationship between insulin-glucose metabolism, nocturnal blood pressure (BP) dipping and cardiac left ventricular mass (LVM) in obese adolescents without diabetes. Methods: A cohort of 206 obese adolescents (mean age 15.4 years (s.d. 1.6), mean body mass index (BMI) 38 kg m -2 (s.d. 5.8), 53% girls) under clinical care were included in the study. Body fat was assessed by dual X-ray absorptiometry (DEXA). Blood samples were drawn for analyses of fasting insulin (fS-insulin), fasting glucose and glycosylated hemoglobin Alc. Homeostatic model assessment index (HOMA index) was calculated. Insulin sensitivity and acute insulin response (AIR) were calculated from the performed frequently sampled intravenous glucose tolerance test. An ambulatory BP measurement was performed and 24 h daytime and nighttime values were calculated. Non-dipping was defined as a nocturnal BP reduction of o10%. Ultrasound was used to measure heart LVM and LVM index (LVMI) was calculated (LVM Â height À2.7 ). Results: Systolic non-dipping was present in 50% (n ¼ 103) of the subjects. Systolic and diastolic dipping was negatively associated with measures of insulin metabolism (HOMA index, fS-insulin and AIR). These associations were present independently of gender, age, daytime BP or body mass index standard deviation score. Dipping (P ¼ 0.7-0.9) or measures of insulin-glucose metabolism (P ¼ 0.3-1.0) were not associated with LVMI in this population. Conclusion: Non-dipping is common among obese adolescents. We found a negative association between nocturnal BP fall (dipping) and measures of insulin metabolism independently of the degree of obesity or daytime BP level among severely obese, non-diabetic adolescents without diagnosed hypertension. Our findings suggest the importance of keeping the insulin levels under observation even in allegedly healthy obese adolescents in clinical care, as a part of the prevention of morbidity associated with obesity.
Introduction
Ambulatory blood pressure (BP) monitoring provides an opportunity to study BP patterns over day and night. In adolescents, nighttime (sleep) systolic BP normally drops by B10% from daytime (awake) BP, that is, the phenomenon of nocturnal dipping. 1 Obese adolescents are at higher risk of reduced nocturnal dipping 2 and individuals with a nondipping pattern may be at increased risk of BP-related complications compared with those with a normal dipping pattern; among children and adolescents with type 1 diabetes, a high nocturnal BP is associated with both cardiac hypertrophy 3 and renal dysfunction. 4, 5 In normotensive adults, failed nocturnal dipping is associated with cardiac hypertrophy. 6 Failed nocturnal dipping also increases the risk for all-cause mortality among adults. 7 The association between nocturnal dipping and morbidity among obese adolescents has not been studied. There is evidence that the lack of nocturnal dipping is associated with impaired insulin and glucose metabolism. Experimentally evoked hyperinsulinemia has been found to decrease dipping among healthy and normal-weight adults. 8 Among children, chronic poor glycemic control may place patients with type 1 diabetes at risk for higher nocturnal BP 4 and fasting insulin (fS-insulin) or HOMA is positively associated with sleep BP among obese children. 9 Obese, but otherwise healthy, adolescents are at higher risk of unfavorable glucose metabolism 10 as well as reduced nocturnal BP dipping 2 compared with normal-weight peers. However, there have only been few studies 9 analyzing the association between insulin-glucose metabolism, nocturnal dipping in obese and non-diabetic adolescents.
On the basis of this discussion, we hypothesize that there is an association between insulin-glucose metabolism and nocturnal BP dipping among obese and non-diabetic adolescents. We also hypothesize that the reduced dipping is associated with left ventricular mass (LVM) in this population.
The purpose of this study was to analyze the relationship between insulin-glucose metabolism, nocturnal dipping and heart LVM in obese adolescents without diabetes. By understanding the associations between risk factors in this population, interventions can be designed to prevent future disease and can be directed at the obese young people at the highest risk.
Materials and methods

Subjects
In this retrospective study, we reviewed a cohort of 282 obese adolescents aged 13-19 years, enrolled at the National Childhood Obesity Center of the Karolinska University Hospital, Huddinge, Sweden, between May 1997 and June 2007. All patients at the center are registered in a national quality registry for childhood obesity, BORIS. Data on all subjects were extracted from this database. The Center receives patients with severe obesity from all parts of Sweden, but the majority comes from the Stockholm region.
Subjects lacking data on ambulatory 24-h BP measurements, age, weight and height were excluded from the study. In addition, three patients with type 2 diabetes 11 were excluded. After exclusion of these subjects, the resulting study cohort comprised 206 adolescents. Age (15.4 vs 15.9 years) and body mass index standard deviation score (BMI SDS) 12 (5.7 vs 5.6) were similar for included and excluded subjects. In 98% of the subjects in this study, measurements were taken within a year from the first visit to the clinic. For the remaining five subjects, 16 months to 5 years had passed since the first visit at the clinic. The treatment offered to all subjects was dietary and as per physical activity advice. The study protocol was approved by the local ethics committee, and written informed consent was obtained from all parents and participants. During the ambulatory BP measurements, systolic and diastolic BPs were measured every 20 min during the day (0700 to 2200 hours) and every 30 min during the night (2200 to 0700 hours). The participants were instructed by nurses to live as usual, but to avoid sporting activities and to record their bed time, time when waking up in the morning and possible awakenings during the night, as well as to report the time and duration of activities that led to an elevated pulse during the 24-h recording period (for example, physical activity and emotion). For the data analysis, the whole 24-h period and the daytime (between 0800 and 2200 hours) and nighttime (between 2400 and 0600 hours) periods were calculated. The percentage of night time reduction in BP ('dipping') was calculated as (daytime BP-nighttime BP) Â 100/daytime BP. Non-dipping was defined as a nocturnal BP reduction of o10%. In the statistical analysis, the variable daytime BP-nighttime BP was included as the dependent variable (see Analysis and statistics section).
Methods
Echocardiogram. Echocardiography was performed by an experienced biomedical scientist using a GE Vingmed System FiVe (Horten, Norway) or Siemens Acuson Sequoia C512 (Malvern, PA, USA). A standard phased array 2.5 MHz multifrequency transducer was used. All recordings were carried out at the end of expiration from apical four-chamber and two-chamber views with the subjects in the left lateral position. Cine loops of two consecutive heartbeats were acquired in each case with a high temporal resolution (90-147 frames s -1 , mean 113). M-mode was used to measure end-diastolic and end-systolic left ventricular diameters, intraventricular septum and posterior wall thicknesses according to the method established by the American Society of Echocardiography. LVM was then calculated by means of the Devereux equation.
14 The LVM index (LVMI) was calculated by dividing LVM by the 2.7th power of height (g Â m À2.7 ).
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Frequently sampled intravenous glucose tolerance test-minimal model analysis. According to the standard protocol, the frequently sampled intravenous glucose tolerance test was performed at 0800 hours in the morning after an overnight fast from 2400 hours. A peripheral intravenous catheter was Bergman, 1994) . S i measures the ability of insulin to enhance glucose disposal and inhibit glucose production. Glucose effectiveness measures the ability of glucose at basal insulin levels to stimulate glucose disposal. The AIR to glucose assesses the adequacy of insulin secretion in the individual. A disposition index was calculated as the product of AIR and S i .
Assays
Blood samples were drawn in the morning after an overnight fast and were subsequently analyzed by the hospital's accredited chemistry laboratory (Department of Clinical Chemistry, Karolinska University Hospital, Huddinge, Sweden). fS-insulin and fasting blood glucose (P-glucose) was measured using standard laboratory techniques. HOMA-IR was calculated using the formula fS-insulin (mU ml In the analysis of variance analysis, square-root transformed data were used for the variables P-glucose, fS-insulin, AIR, disposition index and glucose effectiveness (to obtain normal distributed data). Log-transformed data were used for the variables glycosylated hemoglobin Alc and S i .
Results
The subjects had a mean age of 15.4 years (s.d. 1.4) and were all classified as being obese according to age adjusted BMI 18 (mean 38 kg m -2 , s.d. 5.8, range 27-65). In total, 54% (n ¼ 111) were girls. All subjects were non-diabetic 11 and
were basically normotensive teenagers; only 4% (n ¼ 8) had a mean BP level above 140 mm Hg; however, none were on medication. In all, 49% of the subjects (n ¼ 101) were systolic non-dippers and 13% (n ¼ 26) were diastolic non-dippers. Almost all of the diastolic non-dippers were both systolic and diastolic non-dippers (12% (n ¼ 24)). Anthropometric and clinical characteristics of dippers and non-dippers are presented in Tables 1 and 2 . Systolic dipping was negatively associated with HOMA (Table 3 and Figure 1 ). There was a tendency toward a negative association between systolic dipping and fS-insulin, as well as between diastolic dipping and HOMA index and AIR, respectively. These associations were present independently of gender, age, daytime BP and BMI SDS (Table 3) .
A high BMI SDS was associated with low dipping ( ¼ À0.18 SBP , À0.17 DBP , Po0.01) after adjustment for daytime BP, age and gender. Daytime BP was positively associated with both systolic ( ¼ 0.30, Po0.001) and diastolic ( ¼ 0.46, Po0.001) dipping after adjustment for BMI SDS, age and gender. Diastolic dipping showed an association with gender ( ¼ 0.13, Po0.05): girls had more pronounced diastolic dipping than boys after adjustment for age, daytime diastolic BP and BMI SDS. Age was not associated with nocturnal dipping.
The association between LVMI and nocturnal dipping or insulin-glucose metabolism was evaluated. Adjustments were made for age, gender, daytime BP and BMI SDS. Dipping (P ¼ 0.7-0.9) or measures of insulin-glucose metabolism (same variables as in Table 3 , P ¼ 0.3-1.0) were not associated with LVMI in this population. However, after adjustments for age, gender and BMI SDS, a high daytime BP was associated with high LVMI (Po0.01).
Discussion
We found an association between nocturnal BP fall (dipping) and measures of insulin levels (HOMA index, fS-insulin and AIR) independently of obesity or the daytime BP level among Blood pressure dipping and insulin metabolism M Westerståhl and C Marcus obese non-diabetic adolescents. However, we found no associations between dipping and insulin sensitivity (S i ) or glucose metabolism (P-glucose, glycosylated hemoglobin Alc, disposition index or glucose efficiency). To our knowledge, there is only one study 9 that analyzed the association between dipping and insulin-glucose metabolism in obese, non-diabetic adolescents. Lurbe 9 reported higher sleep systolic BP, but not day:night ratio, among overweight and obese children with a high as compared with a low HOMA index. As the HOMA index primarily reflects insulin levels, 19 this is in agreement with the present results, which indicate that, among obese adolescents, a high insulin level per se, and not insulin resistance, is important in the pathogenesis of non-dipping. This is supported by the findings that experimentally evoked hyperinsulinemia decreases dipping among healthy and normal-weight adults. 8 In addition, adult non-dipper essential hypertensive patients had higher fS-insulin and P-glucose levels and a higher HOMA index than dipper patients. 20 In this study, we found no association between P-glucose and dipping. However, Li et al. 21 found that impaired glucose tolerance tripled the risk of non-dipping among normotensive and non-diabetic adults. The mechanisms behind impaired nocturnal dipping and insulin-glucose metabolism are not fully understood. However, it has been suggested that the presence of hyperinsulinemia and insulin resistance increases sympathetic nerve activity. 22 Also, C-peptide, a cleavage product of proinsulin, Blood pressure dipping and insulin metabolism M Westerståhl and C Marcus might induce the proliferation of vascular smooth muscles, 23 leading to alterations in arteriolar structure and function. In this study, we observed a very high prevalence, approximately 50%, of non-dipping among severely obese adolescents. The clinical consequences of this finding are unclear as we found no correlation between dipping and end-organ damage, measured as cardiac ventricular hypertrophy (LVMI). A non-dipping pattern is associated with cardiac left ventricular hypertrophy among adult normotensive subjects 6 and among children and adolescents with type 1 diabetes. 3 In this population of obese, non-diabetic adolescents, there was no indication that impaired dipping had a negative effect on LVM. However, in agreement with earlier studies, 24 the higher the daytime BP level, the higher is the LVMI among our subjects. It is possible that reduced dipping had prevailed for too short a time in this population to have an affect on LVMI. Our findings have implications for the treatment of obese children and adolescents. Obese young patients are at higher risk for unfavorable fS-insulin levels 25 as well as reduced nocturnal BP dipping. 2 However, these patients are not always diagnosed for these conditions. Our findings suggest a need to keep more carefully the insulin level under observation among these patients in order to prevent increased mortality in adulthood. 7 There is no consensus on the definition of a healthy dipping level for adolescents, however, a reduction of the nighttime BP of o10% is usually regarded as non-dipping. Torbjörnsdotter et al. 5 define impaired dipping in children and adolescents as the population meanF1SD according to reference data. 26 In this study, MANCOVA analyses of correlations were performed to evaluate hypothesized associations with dipping, thus avoiding the need to classify individuals. Some authors have suggested that reduced nocturnal dipping is only a consequence of a higher ratio of sleep:awake activity, 27 although others could observe no difference in activity patterns between dippers and nondippers. 28 We found that daytime BP was positively associated with nocturnal dipping. Therefore, we adjusted for daytime BP levels in the analyses and still found associations with insulin levels. This study has limitations. We could not control for Tanner stages in the analysis because complete data were lacking for the variable. However, existing data indicated that nearly all subjects had reached Tanner stage 4 or 5. At these later stages, insulin metabolism is normalizing after a period of reduced insulin sensitivity in stages 2 and 3.
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Conclusion
Non-dipping is common among obese adolescents. We found a negative association between nocturnal BP fall (dipping) and the HOMA index, fS-insulin or AIR independently of the degree of obesity or daytime BP level among severely obese, non-diabetic adolescents without diagnosed hypertension. However, we did not observe an association between reduced dipping and heart ventricular hypertrophy (LVMI) in this population. Our findings suggest the importance of keeping the insulin levels under observation even in otherwise healthy obese adolescents in clinical care, as a part of the prevention of morbidity associated with obesity.
